Screening participants with inflammatory bowel disease or high colorectal cancer risk in Denmark: a cohort study.

ABSTRACT: Individuals with inflammatory bowel disease (IBC) and high-risk individuals are advised to discuss participation with their doctor and not to participate in colorectal cancer (CRC) screening. Yet a substantial proportion still participate in the Danish faecal immunochemical test (FIT) screening and have a higher positive FIT rate than the average-risk population. We estimated the risk of false-positive screening among individuals with inflammatory bowel disease and high-risk individuals to improve recommendations regarding screening participation. We included 71,871 FIT-positive participants (2014-2017) who had a subsequent colonoscopy within 3 months. Screening outcome within 180 days was established by using registers. We determined that 26,591 of the included participants had a false-po

SUBMITTER: Therkildsen SB 

PROVIDER: S-EPMC11609084 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature